Endocannabinoids in liver disease. (full – 2011) http/onlinelibrary.wiley.com/doi/10.1002/hep.24077/full
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3069975/?toolmcentrez
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis. (full – 2011) http/www.nature.com/cddis/journal/v2/n6/pdf/cddis201152a.pdf
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Cannabis Compound Induces Death Of Cells Associated With Liver Fibrosis (news – 2011) http/www.norml.org/index.cfm?Group_ID=8615
The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes (full – 2012) http/ajpgi.physiology.org/content/302/8/G873.long
Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems (full – 2012) http/jpet.aspetjournals.org/content/340/3/629.full
Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography-Mass Spectrometry. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22946841
Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV-Hepatitis C Coinfection: A Longitudinal Cohort Analysis. (full – 2013) http/cid.oxfordjournals.org/content/early/2013/07/03/cid.cit378.long
Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver (full– 2013) http/onlinelibrary.wiley.com/doi/10.1002/hep.26598/full
US Patent Application 20130171145 - METHODS OF TREATING LIVER DISEASE (full – 2013) http/www.freepatentsonline.com/y2013/0171145.html
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23707465
Anti-hepatitis B virus lignans from the root of Streblus asper. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23434030
Smoking cannabis does not accelerate progression of liver disease in people with HIV/HCV co-infection (news – 2013) http/www.aidsmap.com/Smoking-cannabis-does-not-accelerate-progression-of-liver-disease-in-peoplewith-HIVHCV-co-infection/page/2707524/
Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C. (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4062424/
Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C (full – 2014) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0099450
(Mo1121) Cannabinoid Use Decreases ED Utilization in a Gastroenterology Clinic Population (abst – 2014) http/www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Moderate Cannabis Use Associated with Improved Treatment Response
http://www.hivandhepatitis.com/hep_c…/091506_a.html
Cannabis use improves retention and virological outcomes in patients treated for hepatitis C
http://www.natap.org/2006/HCV/091506_02.htm
Hepatitis C – The Silent Killer Can Medical Cannabis Help?
http://www.pacifier.com/~alive/cmu/hepatitis_c.htm
Study: Pot Helps Hepatitis Treatment
http://www.thehempire.com/index.php/…itis_treatment
Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids
http://molpharm.aspetjournals.org/cg…stract/74/1/20
Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.
http://www.cannabis-med.org/studies/…w.php?s_id=165
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3069975/?toolmcentrez
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis. (full – 2011) http/www.nature.com/cddis/journal/v2/n6/pdf/cddis201152a.pdf
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Cannabis Compound Induces Death Of Cells Associated With Liver Fibrosis (news – 2011) http/www.norml.org/index.cfm?Group_ID=8615
The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes (full – 2012) http/ajpgi.physiology.org/content/302/8/G873.long
Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems (full – 2012) http/jpet.aspetjournals.org/content/340/3/629.full
Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography-Mass Spectrometry. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22946841
Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV-Hepatitis C Coinfection: A Longitudinal Cohort Analysis. (full – 2013) http/cid.oxfordjournals.org/content/early/2013/07/03/cid.cit378.long
Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver (full– 2013) http/onlinelibrary.wiley.com/doi/10.1002/hep.26598/full
US Patent Application 20130171145 - METHODS OF TREATING LIVER DISEASE (full – 2013) http/www.freepatentsonline.com/y2013/0171145.html
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23707465
Anti-hepatitis B virus lignans from the root of Streblus asper. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23434030
Smoking cannabis does not accelerate progression of liver disease in people with HIV/HCV co-infection (news – 2013) http/www.aidsmap.com/Smoking-cannabis-does-not-accelerate-progression-of-liver-disease-in-peoplewith-HIVHCV-co-infection/page/2707524/
Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C. (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC4062424/
Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C (full – 2014) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0099450
(Mo1121) Cannabinoid Use Decreases ED Utilization in a Gastroenterology Clinic Population (abst – 2014) http/www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Moderate Cannabis Use Associated with Improved Treatment Response
http://www.hivandhepatitis.com/hep_c…/091506_a.html
Cannabis use improves retention and virological outcomes in patients treated for hepatitis C
http://www.natap.org/2006/HCV/091506_02.htm
Hepatitis C – The Silent Killer Can Medical Cannabis Help?
http://www.pacifier.com/~alive/cmu/hepatitis_c.htm
Study: Pot Helps Hepatitis Treatment
http://www.thehempire.com/index.php/…itis_treatment
Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids
http://molpharm.aspetjournals.org/cg…stract/74/1/20
Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.
http://www.cannabis-med.org/studies/…w.php?s_id=165